International Multi-Stakeholder Meeting (MSM) on paediatric type I diabetes.

On 21st February, our Project Lead Ricardo Fernandes will participate in the conect4children International Multi-Stakeholder Meeting (MSM) on paediatric type I diabetes.

This meeting will be held in a hybrid format ahead of the Advanced Technologies & Treatments for Diabetes (ATTD) conference in Berlin and is being organized with the European Medicines Agency (EMA).

The main objective of this meeting is to propose a strategy to improve the timely development and access of medical devices for children with type I diabetes, properly addressing paediatric unmet needs, introducing innovative development pathways in the regulatory environment and increasing accessibility for all patients.

Although regulatory decisions will not be taken during the meeting the main conclusions will be a valuable contribution for the future development on this topic.

This meetings aim to facilitate dialogue and provide an opportunity for constructive interactions between relevant stakeholders (patients/patient representatives, clinicians, academics, pharmaceutical companies and regulators) on topics requiring open discussion on development of medicines in the best interests of children and adolescents.

This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 777389. The Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA